SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062203
Filing Date
2023-11-09
Accepted
2023-11-09 17:00:32
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eldn-20230930.htm   iXBRL 10-Q 2048570
2 EX-31.1 eldn-ex31_1.htm EX-31.1 16313
3 EX-31.2 eldn-ex31_2.htm EX-31.2 16647
4 EX-32.1 eldn-ex32_1.htm EX-32.1 10784
5 EX-32.2 eldn-ex32_2.htm EX-32.2 10965
  Complete submission text file 0000950170-23-062203.txt   7118421

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eldn-20230930_pre.xml EX-101.PRE 279243
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eldn-20230930.xsd EX-101.SCH 53110
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eldn-20230930_lab.xml EX-101.LAB 360807
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eldn-20230930_def.xml EX-101.DEF 179469
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eldn-20230930_cal.xml EX-101.CAL 34946
59 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20230930_htm.xml XML 1189178
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 231393545
SIC: 2834 Pharmaceutical Preparations